Clinical Trial Update: Travoprost APS Versus Xalatan® in Patient Reported Outcomes and Ocular Surface Health [Phase 3]

View source ↗

Summary

Phase 3 trial comparing Travoprost APS to Xalatan (latanoprost) in open-angle glaucoma and ocular hypertension, focusing on patient-reported outcomes and ocular…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ocular Hypertension
• Open-angle Glaucoma

Drugs mentioned

• Travoprost APS (travoprost)
• Xalatan (latanoprost)

Snippet

Sponsor: Alcon Research | Conditions: Open Angle Glaucoma, Ocular Hypertension | Phase 3 | Status: COMPLETED